Immune‐mediated thrombocytopenia secondary to suramin Journal Article


Authors: Seidman, A. D.; Schwartz, M.; Reich, L.; Scher, H. I.
Article Title: Immune‐mediated thrombocytopenia secondary to suramin
Abstract: The authors report a case of suramin‐induced immune‐mediated thrombocytopenia occurring in a patient on a Phase II protocol for treatment of metastatic renal cell carcinoma. On withdrawal of suramin, the acute and severe thrombocytopenia did not respond initially to plasmapheresis; subsequently, it resolved promptly and dramatically during the administration of intravenous gamma globulin, also coinciding with a decline in suramin blood levels. Results of immunologic and coagulation studies are reported and clinical implications discussed. Copyright © 1993 American Cancer Society
Keywords: adult; case report; drug withdrawal; disease association; phase 2 clinical trial; thrombocytopenia; immunoglobulin; plasmapheresis; kidney carcinoma; drug blood level; suramin; drug induced disease; intravenous drug administration; middle age; platelets; immune mediated injury; gamma globulin; human; male; priority journal; article; support, non-u.s. gov't; support, u.s. gov't, p.h.s.; immune thrombocytopenia
Journal Title: Cancer
Volume: 71
Issue: 3
ISSN: 0008-543X
Publisher: Wiley Blackwell  
Date Published: 1993-02-01
Start Page: 851
End Page: 854
Language: English
DOI: 10.1002/1097-0142(19930201)71:3<851::Aid-cncr2820710331>3.0.Co;2-m
PUBMED: 8431868
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew D Seidman
    318 Seidman
  2. Lilian M Reich
    99 Reich
  3. Howard Scher
    1130 Scher